Cargando…

Impact of HIV Co-Infection on Clinical Presentation in Patients with TB and Correlation of the Findings with Level of Immune Suppression

BACKGROUND: The Human Immunodeficiency Virus (HIV) has long been known to alter the clinical presentation of tuberculosis (TB), which varies according to the time of occurrence of TB infection and the level of immunodeficiency. Identifying variations in clinical features in HIV-TB coinfection might...

Descripción completa

Detalles Bibliográficos
Autores principales: Takhar, Rajendra Prasad, Mirdha, Kiran, Purohit, Gopal, Maan, Lokesh, Bainara, Mahendra Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Research Institute of Tuberculosis and Lung Disease 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428384/
https://www.ncbi.nlm.nih.gov/pubmed/30915136
_version_ 1783405400961318912
author Takhar, Rajendra Prasad
Mirdha, Kiran
Purohit, Gopal
Maan, Lokesh
Bainara, Mahendra Kumar
author_facet Takhar, Rajendra Prasad
Mirdha, Kiran
Purohit, Gopal
Maan, Lokesh
Bainara, Mahendra Kumar
author_sort Takhar, Rajendra Prasad
collection PubMed
description BACKGROUND: The Human Immunodeficiency Virus (HIV) has long been known to alter the clinical presentation of tuberculosis (TB), which varies according to the time of occurrence of TB infection and the level of immunodeficiency. Identifying variations in clinical features in HIV-TB coinfection might be helpful in settings with limited diagnostic facilities. The aim of this study was to assess the clinical presentation of TB in HIV coinfection and associate clinical findings with level of immune suppression (CD4 count). MATERIALS AND METHODS: In this prospective, cross-sectional observational study 110 patients having TB-HIV co-infection were assessed for clinical presentation and correlation with CD4 count. The study setting was a tertiary care teaching hospital. Patients were categorized in three group based on CD4 counts as group I: ≤ 100 cells/cmm, group II: 101–200 cells/cmm and group III: > 200 cells/cmm. RESULTS: 110 patients were enrolled, 70% had CD4 cell count < 200 cells/mm(3). Mean age and CD4 cell were 33.82±8.79 years and 181.7cells/cmm, respectively. Most common form of tubercular involvement was pulmonary (56.4%) followed by combined pulmonary and extra-pulmonary involvement (28.2%) and exclusively extra-pulmonary (15.5%). No significant intergroup difference was observed in site of involvement among three groups (p=0.700). Cough (91.8%) followed by low grade fever (85.5%), anorexia (82.7%) and weight loss (66.4%) were the commonest presenting symptom without any significant inter group difference. 70.9% patients were in undernourished category and 53.6% were febrile on examination. Sputum negative TB was noted 53.8%. 72.0% of patients with CD4 counts ≤100 had sputum negative TB as compared to sputum positive TB (28%). CONCLUSION: Due to varied clinical presentation of TB in HIV patients, ample knowledge of the clinical spectrum at different levels of immunosuppression is absolutely necessary to identify such patients early.
format Online
Article
Text
id pubmed-6428384
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher National Research Institute of Tuberculosis and Lung Disease
record_format MEDLINE/PubMed
spelling pubmed-64283842019-03-26 Impact of HIV Co-Infection on Clinical Presentation in Patients with TB and Correlation of the Findings with Level of Immune Suppression Takhar, Rajendra Prasad Mirdha, Kiran Purohit, Gopal Maan, Lokesh Bainara, Mahendra Kumar Tanaffos Original Article BACKGROUND: The Human Immunodeficiency Virus (HIV) has long been known to alter the clinical presentation of tuberculosis (TB), which varies according to the time of occurrence of TB infection and the level of immunodeficiency. Identifying variations in clinical features in HIV-TB coinfection might be helpful in settings with limited diagnostic facilities. The aim of this study was to assess the clinical presentation of TB in HIV coinfection and associate clinical findings with level of immune suppression (CD4 count). MATERIALS AND METHODS: In this prospective, cross-sectional observational study 110 patients having TB-HIV co-infection were assessed for clinical presentation and correlation with CD4 count. The study setting was a tertiary care teaching hospital. Patients were categorized in three group based on CD4 counts as group I: ≤ 100 cells/cmm, group II: 101–200 cells/cmm and group III: > 200 cells/cmm. RESULTS: 110 patients were enrolled, 70% had CD4 cell count < 200 cells/mm(3). Mean age and CD4 cell were 33.82±8.79 years and 181.7cells/cmm, respectively. Most common form of tubercular involvement was pulmonary (56.4%) followed by combined pulmonary and extra-pulmonary involvement (28.2%) and exclusively extra-pulmonary (15.5%). No significant intergroup difference was observed in site of involvement among three groups (p=0.700). Cough (91.8%) followed by low grade fever (85.5%), anorexia (82.7%) and weight loss (66.4%) were the commonest presenting symptom without any significant inter group difference. 70.9% patients were in undernourished category and 53.6% were febrile on examination. Sputum negative TB was noted 53.8%. 72.0% of patients with CD4 counts ≤100 had sputum negative TB as compared to sputum positive TB (28%). CONCLUSION: Due to varied clinical presentation of TB in HIV patients, ample knowledge of the clinical spectrum at different levels of immunosuppression is absolutely necessary to identify such patients early. National Research Institute of Tuberculosis and Lung Disease 2018-03 /pmc/articles/PMC6428384/ /pubmed/30915136 Text en Copyright© 2018 National Research Institute of Tuberculosis and Lung Disease http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Takhar, Rajendra Prasad
Mirdha, Kiran
Purohit, Gopal
Maan, Lokesh
Bainara, Mahendra Kumar
Impact of HIV Co-Infection on Clinical Presentation in Patients with TB and Correlation of the Findings with Level of Immune Suppression
title Impact of HIV Co-Infection on Clinical Presentation in Patients with TB and Correlation of the Findings with Level of Immune Suppression
title_full Impact of HIV Co-Infection on Clinical Presentation in Patients with TB and Correlation of the Findings with Level of Immune Suppression
title_fullStr Impact of HIV Co-Infection on Clinical Presentation in Patients with TB and Correlation of the Findings with Level of Immune Suppression
title_full_unstemmed Impact of HIV Co-Infection on Clinical Presentation in Patients with TB and Correlation of the Findings with Level of Immune Suppression
title_short Impact of HIV Co-Infection on Clinical Presentation in Patients with TB and Correlation of the Findings with Level of Immune Suppression
title_sort impact of hiv co-infection on clinical presentation in patients with tb and correlation of the findings with level of immune suppression
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428384/
https://www.ncbi.nlm.nih.gov/pubmed/30915136
work_keys_str_mv AT takharrajendraprasad impactofhivcoinfectiononclinicalpresentationinpatientswithtbandcorrelationofthefindingswithlevelofimmunesuppression
AT mirdhakiran impactofhivcoinfectiononclinicalpresentationinpatientswithtbandcorrelationofthefindingswithlevelofimmunesuppression
AT purohitgopal impactofhivcoinfectiononclinicalpresentationinpatientswithtbandcorrelationofthefindingswithlevelofimmunesuppression
AT maanlokesh impactofhivcoinfectiononclinicalpresentationinpatientswithtbandcorrelationofthefindingswithlevelofimmunesuppression
AT bainaramahendrakumar impactofhivcoinfectiononclinicalpresentationinpatientswithtbandcorrelationofthefindingswithlevelofimmunesuppression